Pages that link to "Q41454224"

The following pages link to Grepafloxacin (Q41454224):

Displaying 16 items.

• Comparative tolerability of the newer fluoroquinolone antibacterials (Q28146268) (← links)
• A critical review of the fluoroquinolones: focus on respiratory infections (Q28215446) (← links)
• Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections (Q28373212) (← links)
• Expanded activity and utility of the new fluoroquinolones: a review (Q33544588) (← links)
• Antimicrobial agents. (Q33660827) (← links)
• Use of newer quinolones for the treatment of intraabdominal infections: focus on clinafloxacin (Q33666710) (← links)
• Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters (Q33895157) (← links)
• The 2-pyridone antibacterial agents: bacterial topoisomerase inhibitors (Q33947205) (← links)
• The new antibiotics (Q34114448) (← links)
• Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics (Q34437719) (← links)
• QT Prolongation and Torsade de Pointes Induced by Fluoroquinolones: Infrequent Side Effects from Commonly Used Medications (Q34634216) (← links)
• The new fluoroquinolones: A critical review (Q35649595) (← links)
• Determination of grepafloxacin and clinafloxacin by capillary zone electrophoresis. (Q43997083) (← links)
• [Safety of the new quinolones]. (Q54341404) (← links)
• Grepafloxacin inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in human airway epithelial cells (Q73440003) (← links)
• Community-acquired pneumonia (Q77464123) (← links)